Fraunhofer Project Center for Stem Cell Process Engineering SPT at MEDICA 2021: Biotechnology / 2021
Stem cells from the bioreactor
![ibmt-spt-bioreactors](/en/ibmt-press-releases-2021/press-stem-cell-bioreactors-2021-11-03/jcr:content/fixedContent/teaserimage.img.1col.jpg/1635920933807/ibmt-spt-bioreactors.jpg)
With the aid of artificial stem cells, it will soon be possible to establish new treatments for previously incurable diseases such as Alzheimer’s disease. At the Fraunhofer Project Center for Stem Cell Process Engineering SPT, a process for the mass production of these so called induced pluripotent stem cells is being developed. This process involves new materials, which ensure that industrial cell production will meet high quality standards. The process will be unveiled to the public for the first time at the MEDICA trade fair in Düsseldorf, Germany, between November 15 and 18, 2021 (hall 3, stand E74).
more info